This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Pseudomembranous colitis
COLITENTER
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
341 |
4. Check minimum number of eventsNone |
341 |
5. Include endpointsNone |
341 |
6. Filter based on genotype QC (FinnGen only) |
304 |
Control definitions (FinnGen only)
- Control exclude
- K11_ENERCOLNONINF
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K52
- Name in latin
- Colitis [haemorrhagica] ex usu antibioticorum
Similar endpoints
↥List of similar endpoints to
Pseudomembranous colitis
based on the number of shared cases.
Similar with more cases:
- Other noninfective gastroenteritis and colitis
- Noninfective enteritis and colitis
- Gastrointestinal diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 304 | 199 | 105 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | 49.45 | 45.27 | 57.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 317
- Matched controls
- 3170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K52.80
ICD-10 Finland
(Hemorrhagic) colitis caused by antibiotics
+∞
307.7
317
*
A07EC02
ATC
mesalazine; oral, rectal
85.9
145.5
78
12
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
55.9
108.9
63
14
A07EA06
ATC
budesonide; oral, local oral
47.3
91.8
55
14
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
22.9
78.1
60
32
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
124.5
72.7
76
8
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
673.8
58.6
56
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
53.7
50
*
UJF32
NOMESCO Finland
Coloscopy
5.3
47.2
147
445
P01AB01
ATC
metronidazole; oral, rectal
5.0
41.9
215
941
K51.5
ICD-10 Finland
Left sided colitis
+∞
39.4
37
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.8
38.3
121
362
C10AC01
ATC
colestyramine; oral
14.1
34.6
33
26
L04AX01
ATC
azathioprine; systemic
12.6
34.2
35
31
K51.8
ICD-10 Finland
Other ulcerative colitis
307.2
28.2
28
*
J01MA02
ATC
ciprofloxacin; systemic
3.2
23.3
168
823
A07AA09
ATC
vancomycin; oral
28.4
23.1
31
12
UJF30
NOMESCO Finland
Ileoscopy through colon
4.8
22.0
55
132
A07EC01
ATC
sulfasalazine; oral, rectal
4.9
19.0
46
107
L01BA01
ATC
methotrexate; systemic
8.2
19.0
26
34
H02AB06
ATC
prednisolone; systemic
2.8
17.8
190
1102
A07EA02
ATC
hydrocortisone; rectal
44.8
17.5
21
5
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.6
17.2
44
107
K59.1
ICD-10 Finland
Functional diarrhoea
5.1
17.1
38
82
A07DA03
ATC
loperamide; oral
7.2
16.8
26
39
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
+∞
15.8
15
*
K50.8
ICD-10 Finland
Other Crohn disease
+∞
15.8
15
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
+∞
15.8
15
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
15.5
117
561
J01FF01
ATC
clindamycin; systemic
2.7
14.7
114
551
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
156.9
14.6
15
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.6
13.7
112
553
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
13.6
13
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
13.6
13
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
146.0
13.6
14
*
H02AB07
ATC
prednisone; oral
3.0
12.9
65
249
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
+∞
12.6
12
*
N06AA09
ATC
amitriptyline; systemic
3.3
11.6
47
157
K51
ICD-10 Finland
Ulcerative colitis
+∞
11.5
11
*
K50.1
ICD-10 Finland
Crohn disease of large intestine
+∞
11.5
11
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
10.9
137
804
N02AX02
ATC
tramadol; systemic, rectal
2.2
10.5
156
973
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.8
10.5
33
93
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
10.5
10
*
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
10.5
10
*
J01MA12
ATC
levofloxacin; systemic
2.5
10.4
76
351
A02BC03
ATC
lansoprazole; oral
2.3
10.2
111
610
A02BC01
ATC
omeprazole; systemic
2.3
10.2
108
587
J01FA06
ATC
roxithromycin; oral
2.1
9.9
148
921
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.1
9.5
43
154
N03AX12
ATC
[U] gabapentin; oral
2.5
9.4
66
297
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
9.4
9
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
9.2
82
412
UJF92
NOMESCO Finland
Capsular endoscopy
16.2
9.1
14
9
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.8
8.9
28
79
N05CD07
ATC
temazepam; oral
2.7
8.9
52
214
A07AA02
ATC
nystatin; oral
3.5
8.7
31
95
M13.9
ICD-10 Finland
Arthritis, unspecified
3.3
8.6
34
112
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.4
8.2
31
99
A46
ICD-10 Finland
Erysipelas
2.5
8.1
58
263
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
8.0
30
95
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.4
8.0
20
33
N06AB04
ATC
citalopram; systemic
2.2
7.9
82
437
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
15.5
7.8
12
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
7.7
51
222
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.6
7.6
47
198
A01AB09
ATC
miconazole; local oral
2.7
7.5
42
168
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.9
7.5
36
133
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.2
7.5
20
50
K56.7
ICD-10 Finland
Ileus, unspecified
8.7
7.4
15
18
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
7.3
7
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
7.3
49
215
A02BX02
ATC
sucralfate; oral
4.1
7.3
20
51
A06AD11
ATC
lactulose; oral
2.3
7.2
61
298
K92.1
ICD-10 Finland
Melaena
3.6
7.0
23
67
L04AB04
ATC
adalimumab; parenteral
8.6
6.9
14
17
A02BA02
ATC
ranitidine; systemic
2.1
6.9
75
405
D94
ICPC
Chronic enteritis/ulcerative colitis
41.0
6.8
8
*
L01BB02
ATC
mercaptopurine; oral
41.0
6.8
8
*
L04AX03
ATC
methotrexate; systemic
2.6
6.7
39
160
J02AC01
ATC
fluconazole; systemic
1.9
6.6
135
903
N03AE01
ATC
clonazepam; systemic
3.2
6.6
26
85
WX002
NOMESCO Finland
Sedation and analgesia
2.2
6.6
64
330
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
6.6
75
412
C03CA01
ATC
furosemide; systemic
1.9
6.4
107
670
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
6.4
32
121
P01BA02
ATC
hydroxychloroquine; oral
2.7
6.3
35
140
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
6.3
44
197
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
+∞
6.3
6
*
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
+∞
6.3
6
*
A07EA01
ATC
prednisolone; oral, rectal
+∞
6.3
6
*
ZX120
NOMESCO Finland
Intravenous
2.6
6.3
39
165
SPAT1263
SPAT
Sampling
1.8
6.2
132
891
G01AF05
ATC
econazole; vaginal
2.8
6.2
32
123
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
7.9
6.2
13
17
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.2
6.2
24
78
H02AB04
ATC
methylprednisolone; systemic
2.2
6.1
55
274
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
6.1
73
406
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
6.1
19
53
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
6.1
20
58
E000003, ,
ATC
3.5
6.1
21
63
A02BA04
ATC
nizatidine; systemic
2.8
6.1
31
118
A02BC02
ATC
pantoprazole; systemic
1.9
6.0
217
1710
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
69
162
5.17
28.64
2.3
1.5
—
—
—
0
0
90
293
3.89
24.16
5.0
1.3
219.20
101.90
ug/g
1.53
75
217
25
74
3.58
7.41
1.8
1.3
—
—
—
0
0
56
270
2.30
6.78
2.5
1.9
388.34
382.13
nmol/l
0.07
50
255
159
1121
1.84
6.58
8.1
4.1
35.92
35.97
g/l
0.04
150
1060
124
826
1.82
6.05
3.8
2.3
57.81
68.08
u/l
0.68
118
768
132
916
1.76
5.49
3.7
2.8
29.32
30.02
u/l
0.13
126
869
170
1270
1.73
5.41
4.7
2.9
110.05
103.31
ug/l
0.18
164
1194
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
58
3.42
5.39
3.8
2.5
0.25
0.39
iu/ml
—
7
32
183
1399
1.73
5.33
6.0
5.8
10.28
11.05
umol/l
0.30
175
1332
59
323
2.02
5.13
11.6
5.6
1.07
1.04
mmol/l
0.43
54
294
69
403
1.91
4.98
3.8
2.4
2.31
2.31
g/l
0.01
63
370
159
1191
1.67
4.82
3.5
2.5
77.58
77.18
nmol/l
0.05
151
1075
71
426
1.86
4.70
3.9
2.4
12.78
13.46
umol/l
0.27
66
399
110
759
1.69
4.49
4.2
3.0
0.58
0.43
e6/l
0.17
86
542
21
77
2.85
4.44
1.9
1.6
—
—
—
0
0
13
28
4.79
4.42
1.9
1.3
—
—
—
0
0
35
167
2.23
4.33
4.4
2.5
228.35
182.84
ng/l
0.23
30
150
80
518
1.73
4.07
2.0
1.7
97143293.49
11415974.10
pmol/l
0.42
70
438
68
431
1.74
3.71
3.4
2.8
0.82
0.82
mmol/l
0.07
62
407
46
261
1.89
3.59
5.6
3.5
1.82
1.73
mmol/l
0.06
41
225
17
64
2.75
3.45
1.3
1.3
—
—
—
0
0
66
426
1.69
3.36
2.0
1.7
1112.39
1204.13
nmol/l
0.37
51
318
51
307
1.79
3.31
2.3
1.8
—
—
—
0
0
53
323
1.77
3.30
2.3
1.7
—
—
—
0
0
48
286
1.80
3.22
2.2
2.2
6.26
6.66
umol/l
0.05
42
248
176
1437
1.51
3.19
5.7
4.0
0.00
0.00
estimate
-0.00
40
298
48
287
1.79
3.18
6.2
7.0
-0.39
1.04
mmol/l
0.69
33
240
70
466
1.64
3.16
3.2
2.6
0.68
1.12
e6/l
1.31
41
241
88
623
1.57
3.08
6.0
4.2
1.02
1.02
kg/l
0.60
63
417
184
1524
1.49
3.06
12.5
9.6
4.11
4.05
e9/l
0.15
171
1323
5
5
10.13
2.99
1.6
1.0
—
—
—
0
0
65
433
1.63
2.92
2.5
1.8
—
—
—
0
0
9
22
4.18
2.90
2.3
1.2
—
—
—
0
0
143
1141
1.46
2.78
2.5
2.1
97.43
96.86
pmol/l
0.05
69
584
17
72
2.44
2.77
1.4
1.1
—
—
—
0
0
75
525
1.56
2.73
5.4
3.6
290.57
371.75
ng/l
0.12
55
397
92
675
1.51
2.71
2.7
2.7
346.73
338.29
umol/l
0.34
75
599
17
73
2.40
2.70
1.4
1.1
—
—
—
0
0
36
208
1.82
2.68
2.0
2.2
0.24
0.22
g/l
1.24
31
191
174
1451
1.44
2.63
5.8
4.0
0.00
0.01
estimate
0.50
37
285
17
74
2.37
2.63
1.9
1.3
—
—
—
0
0
88
645
1.50
2.59
1.5
1.3
0.94
1.54
u/ml
0.63
19
186
227
1995
1.49
2.57
12.5
7.3
73.51
78.61
u/l
1.94
219
1889
14
56
2.57
2.56
7.1
3.4
10.79
9.71
pmol/l
0.15
14
56
171
1426
1.43
2.56
5.6
4.0
0.00
0.00
estimate
-0.00
42
291
144
1164
1.43
2.56
9.6
5.8
1.21
1.21
mmol/l
0.13
134
1070
9
26
3.53
2.50
1.1
1.3
—
—
—
0
0
21
103
2.11
2.48
1.4
1.5
—
—
—
0
0
136
1094
1.43
2.46
5.9
3.9
0.06
0.03
estimate
0.18
33
243
17
77
2.28
2.42
4.9
3.7
1.14
2.58
ratio
—
10
42
84
623
1.47
2.31
1.9
1.6
1.11
1.22
mg/l
0.11
61
493
16
72
2.29
2.31
1.4
1.3
287.22
309.12
ug/g
—
9
36
54
364
1.58
2.31
7.5
6.1
104.37
104.11
mmol/l
0.15
54
364
35
214
1.71
2.18
1.4
1.4
—
—
—
0
0
155
1295
1.39
2.17
12.5
6.7
1.22
1.21
mmol/l
0.23
136
1118
6
14
4.35
2.16
3.0
4.1
365.50
197.14
nmol/l
—
6
14
12
49
2.51
2.13
2.1
1.3
—
—
—
0
0
12
49
2.51
2.13
2.1
1.3
—
—
—
0
0
22
119
1.91
2.03
1.8
1.5
0.18
0.27
mg/l
0.35
12
46
33
203
1.70
2.02
7.4
3.6
108.52
86.50
ng/l
0.59
27
177
5
11
4.60
1.95
1.2
1.4
—
—
—
0
0
21
362
0.55
1.92
2.4
3.0
0.81
0.84
ug/l
—
10
217
7
22
3.23
1.89
1.1
1.0
—
—
—
0
0
9
35
2.62
1.81
2.6
1.3
—
—
—
0
0
7
23
3.09
1.81
1.3
2.0
—
—
—
0
0
94
744
1.37
1.77
2.0
1.7
21.41
20.99
nmol/l
0.08
84
631
6
18
3.38
1.75
2.8
1.4
—
—
—
0
0
217
1954
1.35
1.70
6.9
4.1
14.60
11.29
mm/h
2.23
207
1821
16
83
1.98
1.67
1.3
1.2
—
—
—
0
0
58
426
1.44
1.67
3.6
2.8
0.80
3.28
e6/l
3.69
29
203
64
479
1.42
1.66
1.5
1.3
14.60
10.66
u/ml
0.11
25
192
28
175
1.66
1.64
2.0
1.9
—
—
—
0
0
69
527
1.40
1.60
1.5
1.3
24.96
28.61
iu/ml
0.19
19
166
24
145
1.71
1.59
2.0
1.9
—
—
—
0
0
11
217
0.49
1.55
1.6
1.9
3.42
3.49
mmol/l
—
5
165
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
15
3.37
1.53
1.2
1.9
140.60
116.07
%
—
5
15
7
27
2.63
1.52
1.7
1.4
—
—
—
0
0
7
27
2.63
1.52
1.7
1.4
—
—
—
0
0
97
792
1.32
1.47
6.5
4.1
0.00
0.01
estimate
0.50
34
271
5
16
3.16
1.44
2.6
2.3
—
—
—
0
0
6
22
2.76
1.44
4.2
4.6
3.42
3.09
nmol/l
—
6
22
143
1234
1.29
1.43
3.5
2.7
—
—
estimate
—
0
0
223
2402
0.76
1.41
4.5
4.2
1.32
1.27
mmol/l
0.44
207
2234
22
135
1.68
1.40
1.4
1.3
—
—
—
0
0
175
1553
1.28
1.40
7.2
4.6
6.64
6.61
mmol/l
0.05
163
1463
229
2452
0.76
1.33
5.6
5.0
5.83
5.92
mmol/l
0.65
214
2272
30
202
1.54
1.33
3.8
2.7
49.38
65.10
ml/min/173m2
1.40
13
83
98
813
1.30
1.31
4.9
3.4
0.03
0.01
estimate
0.24
31
228
94
777
1.30
1.29
3.0
3.3
1577.40
1284.02
ng/l
0.19
79
664
10
49
2.07
1.23
2.1
1.6
—
—
—
0
0
99
829
1.28
1.23
5.0
4.1
15.05
8.97
mg/mmol
0.63
59
513
8
37
2.19
1.22
1.3
1.4
94.91
52.42
ug/l
—
8
37
108
916
1.27
1.21
3.9
3.3
2.33
2.36
mmol/l
1.38
98
849
8
39
2.08
1.16
2.4
1.5
—
—
—
0
0
5
20
2.52
1.15
1.0
1.2
111.20
101.95
pmol/l
—
5
20
7
30
2.36
1.13
2.6
1.4
—
—
—
0
0
7
31
2.29
1.11
1.3
1.1
—
—
—
0
0
98
830
1.26
1.10
2.7
2.1
117.68
189.70
u/l
2.14
90
788
5
21
2.40
1.09
1.8
2.3
—
—
—
0
0
12
67
1.82
1.06
2.7
3.0
1.50
2.50
index
—
6
44
37
484
0.73
0.99
4.5
4.3
19.64
22.25
%
0.49
13
218
10
54
1.88
0.97
1.3
1.5
—
—
—
0
0
115
1006
1.22
0.95
4.6
3.9
57.60
36.32
ng/l
0.31
73
686
6
27
2.24
0.94
1.7
1.4
—
—
—
0
0
6
27
2.24
0.94
1.2
1.4
—
—
—
0
0
6
28
2.16
0.92
1.2
1.4
—
—
—
0
0
6
28
2.16
0.92
1.2
1.4
—
—
—
0
0
245
2569
0.80
0.91
6.1
5.6
2.65
2.74
mmol/l
0.87
230
2409
8
42
1.93
0.89
1.5
1.8
—
—
—
0
0
240
2518
0.81
0.86
5.2
4.9
1.46
1.50
mmol/l
0.85
225
2355
75
634
1.24
0.85
3.2
2.1
—
—
—
0
0
242
2534
0.81
0.83
5.4
5.0
4.59
4.69
mmol/l
0.84
229
2384
62
515
1.25
0.82
1.8
1.6
—
—
—
0
0
10
58
1.75
0.80
4.0
1.8
—
—
—
0
0
6
33
1.83
0.79
1.0
1.0
—
—
—
0
0
33
253
1.34
0.79
5.0
3.2
—
—
—
0
0
268
2772
0.79
0.78
39.4
23.4
131.45
134.52
g/l
2.89
268
2742
229
2169
1.20
0.74
32.5
19.1
13.92
13.62
%
2.17
224
2149
5
26
1.94
0.71
1.2
2.3
11.60
22.08
ug/l
—
5
26
11
69
1.62
0.69
2.4
1.4
—
—
—
0
0
39
314
1.28
0.68
2.8
1.9
1.45
1.39
%
0.21
34
280
7
43
1.64
0.67
1.3
1.4
—
—
—
0
0
10
62
1.63
0.66
2.0
1.4
—
—
—
0
0
22
289
0.74
0.63
1.5
2.0
3.46
3.41
ratio
0.06
14
237
11
72
1.55
0.60
2.3
1.4
—
—
—
0
0
191
1805
1.15
0.55
4.4
3.2
45.40
45.44
u/l
0.00
183
1715
6
40
1.51
0.52
2.5
1.5
—
—
—
0
0
236
2444
0.87
0.50
24.4
14.7
80.57
81.26
ml/min/173m2
0.18
224
2262
175
1663
1.12
0.42
3.4
3.2
—
—
—
0
0
8
58
1.39
0.42
2.5
1.3
—
—
—
0
0
28
232
1.23
0.41
4.0
2.7
0.68
0.55
e6/l
0.09
28
222
0
15
0.00
0.41
0.0
1.1
—
1.21
—
0
8
0
16
0.00
0.41
0.0
1.1
—
204.43
—
0
16
9
66
1.37
0.38
2.3
1.4
—
—
—
0
0
55
489
1.15
0.38
1.4
1.5
—
—
—
0
0
17
134
1.28
0.37
1.1
1.1
—
—
—
0
0
18
144
1.27
0.36
2.1
1.5
—
—
—
0
0
6
42
1.44
0.35
1.5
1.6
—
—
—
0
0
35
303
1.17
0.34
2.0
2.0
—
—
—
0
0
12
91
1.33
0.34
1.7
1.3
5.96
7.69
u/ml
—
5
16
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
13
101
1.30
0.32
4.3
2.1
3025.85
3332.74
u/l
—
6
36
7
52
1.35
0.31
2.3
1.5
—
—
—
0
0
7
54
1.30
0.30
2.4
1.4
—
—
—
0
0
38
336
1.15
0.30
2.1
2.2
—
—
—
0
0
264
2690
0.89
0.29
18.2
11.2
25.65
25.65
u/l
0.00
256
2628
59
540
1.11
0.28
4.5
2.7
2.45
2.45
mmol/l
0.00
53
491
17
141
1.22
0.26
1.4
1.4
—
—
—
0
0
13
106
1.24
0.23
1.3
1.3
104.00
239.67
miu/ml
—
6
48
56
605
0.91
0.23
4.1
4.8
3.64
2.20
ug/l
0.60
48
539
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
212
2070
1.07
0.21
5.5
4.5
14.48
14.70
pmol/l
0.74
198
1907
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
7.71
—
0
14
12
101
1.20
0.17
1.5
1.8
—
—
—
0
0
8
73
1.10
0.16
1.0
1.1
—
7.99
—
0
14
21
192
1.10
0.11
1.3
1.3
20.00
162.53
u/ml
—
10
80
5
44
1.14
0.10
1.0
1.4
—
—
—
0
0
5
44
1.14
0.10
1.0
1.4
—
144.00
—
0
5
6
56
1.07
0.08
1.2
1.3
—
—
—
0
0
238
2403
0.96
0.08
7.3
6.2
39.64
39.19
mmol/mol
0.34
226
2274
10
88
1.14
0.08
2.4
2.9
—
—
—
0
0
6
75
0.80
0.07
1.0
1.2
—
—
—
0
0
8
78
1.03
0.07
1.6
1.2
—
—
—
0
0
9
102
0.88
0.06
1.2
1.7
—
—
—
0
0
112
1100
1.03
0.06
2.4
1.9
1.51
1.36
mmol/l
1.22
97
933
239
2408
0.97
0.06
6.6
5.5
1.80
1.85
mu/l
0.27
219
2236
10
93
1.08
0.02
3.0
1.9
—
—
—
0
0
256
2568
0.98
0.01
29.1
14.9
19.60
22.53
mg/l
1.12
228
2119
18
174
1.04
0.00
11.9
8.5
1.33
1.38
%
0.07
18
174
27
276
0.98
0.00
9.4
7.3
—
—
—
0
0
10
102
0.98
0.00
1.1
1.1
1.38
1.59
g/l
—
10
102
17
168
1.01
0.00
12.6
8.8
0.70
0.66
%
0.12
17
168
10
103
0.97
0.00
1.1
1.1
0.79
0.91
g/l
—
10
103
6
69
0.87
0.00
3.2
4.4
15.53
29.88
mg/l
—
6
49
0
6
0.00
-0.00
0.0
2.0
—
1.20
—
0
6
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
12.36
—
0
5
0
5
0.00
-0.00
0.0
4.2
—
69.12
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
52.40
—
0
5
9
91
0.99
-0.00
3.1
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
43.20
—
0
6
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: COLITENTER – Pseudomembranous colitis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).